Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/26/2007EP1751138B1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
12/26/2007EP1750688B1 Steroid intraocular implants having an extended sustained release for a period of greater than 2 months
12/26/2007EP1711465B1 Hydroisoindoline tachykinin receptor antagonists
12/26/2007EP1691744A4 Methods and reagents for the treatment of inflammatory disorders
12/26/2007EP1689717B1 Substituted isoquinolines useful in the treatment of diseases such as cancer and atherosclerosis
12/26/2007EP1680121A4 Methods and reagents for the treatment of immunoinflammatory disorders
12/26/2007EP1654036B1 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
12/26/2007EP1622624B1 Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics
12/26/2007EP1615663B1 Agent for treating leishmania infections
12/26/2007EP1597248B1 Sulfonamide derivatives as ppar modulators
12/26/2007EP1567137B1 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
12/26/2007EP1539750B1 Pyrazolopyridines as cyclin dependent kinase inhibitors
12/26/2007EP1539708B1 Benzimidazolones and their use as cytokine inhibitors
12/26/2007EP1525193B1 Acylaminothiazole derivatives, preparation and therapeutic use thereof
12/26/2007EP1503797B1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
12/26/2007EP1491531B1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative
12/26/2007EP1476144A4 Synergistic mixtures of o-phenylphenol and other nitrogen and aldehyde microbiocides
12/26/2007EP1476139A4 Controlled release dosage forms
12/26/2007EP1441714B1 Combinations comprising a selective cyclooxygenase-2 inhibitor
12/26/2007EP1429734B1 Controlled release solid dispersions of carvedilol
12/26/2007EP1402894B1 Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives
12/26/2007EP1351919B1 Retinol derivatives and process for preparing same
12/26/2007EP1339430B1 Freeze-dried pantoprazole preparation and pantoprazole injection
12/26/2007EP1333810B1 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
12/26/2007EP1330999B1 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative
12/26/2007EP1282365B1 Preparation for the prevention and/or treatment of vascular disorders
12/26/2007EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/26/2007EP1261363B1 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS
12/26/2007EP1233769B1 Imidazole derivatives
12/26/2007EP1187835B1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
12/26/2007EP1171137B1 Use of triacetyluridine for the treatment of mitochondrial disorders
12/26/2007EP1085855A4 Enhanced intra vaginal devices
12/26/2007EP1045703A4 Stabilization of lipid:dna formulations during nebulization
12/26/2007EP0850646B1 Liposome preparations of indolocarbazole derivatives
12/26/2007EP0837630B1 Prodrugs of pharmaceuticals with improved bioavailability
12/26/2007EP0817621B2 Pharmaceutical composition for transdermic delivery
12/26/2007EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
12/26/2007CN101094854A Constrained compounds as cgrp-receptor antagonists
12/26/2007CN101094853A Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
12/26/2007CN101094852A Substituted indolizines and derivatives as cns agents
12/26/2007CN101094851A Novel compound having lipase inhibitory activity
12/26/2007CN101094847A Aryloxy-substituted benzimidazole derivatives
12/26/2007CN101094846A 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists
12/26/2007CN101094844A Chroman derivatives, medicaments and use in therapy
12/26/2007CN101094843A Insecticidal 3-(dihaloalkenyl)phenyl derivatives
12/26/2007CN101094839A Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives
12/26/2007CN101094837A Novel beta agonists, method for producing the same and their use as drugs
12/26/2007CN101094835A Novel dicarboxamide derivatives
12/26/2007CN101094832A Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
12/26/2007CN101094692A Improved quenching methods for red blood cell inactivation process
12/26/2007CN101094690A Compositions and methods for treating a posterior segment of an eye
12/26/2007CN101094687A Nutritional composition comprising indigestible oligosaccharides
12/26/2007CN101094680A Regimens for intra-articular viscosupplementation
12/26/2007CN101094679A Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
12/26/2007CN101094678A Blood cholesterol reducing oral composition
12/26/2007CN101094677A Protein tyrosine phosphatase inhibitors and methods of use thereof
12/26/2007CN101094676A Use of androgens to reduce the likelihood of acquiring or to treat skin aging
12/26/2007CN101094675A Formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives
12/26/2007CN101094674A Use of n-desmethylclozapine to treat human neuropsychiatric disease
12/26/2007CN101094673A Combination comprising zd6474 and an antiandrogen
12/26/2007CN101094672A 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
12/26/2007CN101094671A Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor
12/26/2007CN101094670A Oxime substituted imidazoquinolines
12/26/2007CN101094669A Indometacin-containing adhesive patch
12/26/2007CN101094668A Use of selected compounds for protection of neurones and oligodendrocytes in the treatment of multiple sclerosis
12/26/2007CN101094667A Hypocholesterolemic compositions comprising a statin and an antiflatulent agent
12/26/2007CN101094666A Improvement of image quality in the eye
12/26/2007CN101094665A Use of certain phenyl napthyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms)
12/26/2007CN101094664A Use of certain phenyl-naphthyl compounds that do not have significant affinity to er alpha or er beta for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis
12/26/2007CN101094662A Hydrous adhesive patch
12/26/2007CN101094661A Modified release tablet formulations for proton pump inhibitors
12/26/2007CN101094660A New modif ied release peelet formulat ions for proton pump inhibitors
12/26/2007CN101094659A Nanoparticle composition and methods for synthesis thereof
12/26/2007CN101094656A Oral solid dosage forms containing a low dose of estradiol
12/26/2007CN101094650A Compositions and methods for reducing scar tissue formation
12/26/2007CN101092442A Steroid compounds having contraceptive and anti-osteoporosis activity
12/26/2007CN101092441A Method for synthesizing nelarabine
12/26/2007CN101092433A Cis [( trans 1R, 2R 1,2 cyclohexane diamine) .(beta ¿C phenyl isosuccinic acid radical) platinum (ó�)] complexes, and usage as anticancer medicine
12/26/2007CN101092432A Superoxide dismutase mimics for the treatment of ocular disorders and diseases
12/26/2007CN101092431A Derivative of organic phosphorus of containing structure of spirocyclic / cyclopropane, preparation method and application
12/26/2007CN101092420A (1Z, 4Z, 5Z) ¿C 6 N isopropyl ¿C 6 - aza ¿C2 ¿C oxo ¿C 3 - oxa ¿C 4 ¿C methoxy ¿C dicyclo [3, 1, 0] hexane and preparation method
12/26/2007CN101092419A (1Z, 4Z, 5Z) ¿C 6 N alkyl ¿C 6 ¿C aza ¿C2 ¿C oxo ¿C 3 ¿C oxa ¿C 4 ¿C methoxy ¿C dicyclo [3, 1, 0] hexane and preparation method
12/26/2007CN101092417A Folacin analogue, and salt of folacin analogue in use for medical treatment
12/26/2007CN101092416A Derivative of folacin alkylation and application
12/26/2007CN101092415A Compound of new benzo heterocycle categories, preparation method and application
12/26/2007CN101092414A Preparation and application of a category of 6 ¿C aryl ¿C 3 ¿C cycroamido methyl pyrone derviation
12/26/2007CN101092413A Hydrate of medicinal salt of Fasudil
12/26/2007CN101092409A C-aryl glucoside sglt2 inhibitors and method
12/26/2007CN101092408A Lactone compound of sweetsop connected through amido bond, synthetic method and application
12/26/2007CN101092405A Derivative of new benzothiadiazines, preparation method and usage
12/26/2007CN101092402A New compound in sulfonyl ureas, and medicine use
12/26/2007CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors
12/26/2007CN101092397A Structure modified compound of sinomenine, and prepartion method
12/26/2007CN101092394A Method for preparing Meixianduoxin
12/26/2007CN101092388A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
12/26/2007CN101092384A A category of compound of alpha ¿C amido - N ¿C substituent amide, its composition, and application
12/26/2007CN101092375A Compound of amide diketone acid, preparation method and application
12/26/2007CN101092363A Compound of lignan in aryl tetrahydronaphthalene, preparartion method and application
12/26/2007CN101092342A Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds
12/26/2007CN101091779A Powder of bluestone for burn
1 ... 3446 3447 3448 3449 3450 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 3461 3462 3463 3464 3465 3466 ... 7860